Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.56 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.56 |
| ▸ | ACE | P12821 | 3/20 | 0.55 |
| ▸ | CPA1 | P15085 | 3/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.55 |
| ▸ | GNPAT | O15228 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11799997 | 1.00 | MME (0.56) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL29531510 | 0.97 | MME (0.58) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL29470194 | 0.97 | MME (0.58) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL10646220 | 0.97 | MME (0.58) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL10646215 | 0.97 | MME (0.58) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL30799679 | 0.95 | CTRB1 (0.56) | MMECTRB1ACE | |
| SCHEMBL29702065 | 0.94 | MME (0.61) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL13252769 | 0.94 | MME (0.52) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL30799461 | 0.94 | MME (0.54) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL30799731 | 0.94 | MME (0.55) | MMECTRB1ACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | MME 467/4885CTRB1 2805/4885ACE 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.